Daniel Pascoalino Pinheiro

6PUBLICATIONS
35CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersPharmacogenomicsOrganometallic chemistryBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2024
Hypomethylation at H19DMR in penile squamous cell carcinoma is not related to HPV infection.

Renan da Silva Santos, Daniel Pascoalino Pinheiro, Carlos Gustavo Hirth

|Nov 16, 2022
Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics.

José Ednésio da Cruz Freire, José Edvar Monteiro Júnior, Daniel Pascoalino Pinheiro

|Sep 16, 2021
CRISPR/Cas9 small promoter deletion in H19 lncRNA is associated with altered cell morphology and proliferation.

Renan da Silva Santos, Daniel Pascoalino Pinheiro, Louhanna Pinheiro Rodrigues Teixeira

|Sep 05, 2020
The Effects of the Alkaloid Tambjamine J on Mice Implanted with Sarcoma 180 Tumor Cells.

Francisco Washington A Barros-Nepomuceno, Daniel de Araújo Viana, Daniel Pascoalino Pinheiro

Pageof 1